Top compounds associated with response to CTD-3105H18.16

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	selumetinib:navitoclax (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.06	0.1
mRNA	B02	CTRPv2	pan-cancer	AAC	0.059	0.1
mRNA	MGCD-265	CTRPv2	pan-cancer	AAC	0.056	0.1
mRNA	SJ-172550	CTRPv2	pan-cancer	AAC	0.062	0.1
mRNA	TGX221	CTRPv2	pan-cancer	AAC	-0.06	0.1
mRNA	alisertib:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.056	0.1
mRNA	BRD-K14844214	CTRPv2	pan-cancer	AAC	0.062	0.1
mRNA	Crizotinib	CTRPv2	pan-cancer	AAC	0.052	0.1
mRNA	JQ-1:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.054	0.1
mRNA	SID 26681509	CTRPv2	pan-cancer	AAC	0.06	0.1

Download CSV